Financials
- Market Capitalization 3.53 B
- Employee 601
- Founded 2015
- CEO -
- Website www.arcusbio.com
- Headquarter Delaware, United States
- FIGI BBG00DQD26W3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1563 | GPCR Structure Therapeutics Inc - American Depositary Shares | 51.64 USD | -3.22% | -8.71% | +20.09% | +93.12% | 3.67 B USD | ||
| 1575 | RLAY Relay Therapeutics, Inc. - Common Stock | 18.73 USD | -6.40% | -1.27% | +24.53% | +424.65% | 3.59 B USD | ||
| 1600 | ALMS Alumis Inc. - Common Stock | 28.10 USD | -0.74% | +1.52% | +15.21% | +523.06% | 3.47 B USD | ||
| 1614 | ARQT Arcutis Biotherapeutics, Inc. - Common stock | 27.12 USD | -2.24% | +3.12% | +10.15% | +70.14% | 3.39 B USD |
Frequently asked questions about Arcus Biosciences, Inc. Common Stock
What is the Arcus Biosciences, Inc. Common Stock stock price today?
The current price of Arcus Biosciences, Inc. Common Stock (RCUS) is 28.08. Over the past 24 hours, the stock has changed by -2.90%. Follow the RCUS chart for real-time price dynamics.
What is the stock ticker of Arcus Biosciences, Inc. Common Stock?
Arcus Biosciences, Inc. Common Stock trades under the ticker RCUS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Arcus Biosciences, Inc. Common Stock stock going up?
RCUS has changed by -7.17% over the last week, +15.03% over the last month, and +190.08% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Arcus Biosciences, Inc. Common Stock net income for the last quarter?
Arcus Biosciences, Inc. Common Stock reported net income of -128 M for the last quarter. The previous quarter showed -106 M, which means net income changed by -20.75%.
How many employees does Arcus Biosciences, Inc. Common Stock have?
As of the latest available data, Arcus Biosciences, Inc. Common Stock has 601 employees. Workforce size can provide additional context about the company's scale and operations.
What is Arcus Biosciences, Inc. Common Stock EBITDA?
Arcus Biosciences, Inc. Common Stock EBITDA is -137 M, and its EBITDA margin is -805.88%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Arcus Biosciences, Inc. Common Stock stock?
You can buy Arcus Biosciences, Inc. Common Stock (RCUS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Arcus Biosciences, Inc. Common Stock stock?
Investing in Arcus Biosciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RCUS chart and related analysis on metatrader.com as part of your research.